Latest Intravenous immunoglobulin Stories
Immune globulin replacement began decades ago as a treatment for patients who could not make their own protective antibodies, but has proven to have much broader benefits than originally expected.
A new study presented on July 17th, 2012, at the Alzheimer's Association International Conference 2012 in Vancouver revealed Alzheimer's disease symptoms long-term (three-year) stabilization
Specialty biotech distributor BDI Pharma announced that Sales Revenues through the first two fiscal quarters of 2012 represented an increase of more than thirty-five percent (35%) compared with
- totally perplexed and mixed up.